## QLYS: Qualys, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -5.5% below STRENGTH zone (3.0-6.0%); PEG 3.90 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($130.62)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 4 ($0.00M) |
| Sells | 14 ($3.97M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Blackrock Inc.: 15.3% (-2.6%)
- Vanguard Group Inc: 12.3% (+2.9%)
- State Street Corpora: 3.9% (-1.6%)
- Geode Capital Manage: 3.4% (+0.3%)
- Boston Trust Walden : 3.2% (+0.7%)

### Key Risks

1. Momentum deterioration: MRS_10 falling (-4.0% 5d) with bearish MACD, trend may be turning.
2. Insider selling cluster: $4.0M in recent transactions.
3. Valuation stretched: PEG 3.9x requires aggressive growth execution.
4. Elevated short interest (12.4%): bears positioning against stock.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 3.90 signals overvaluation risk, limited margin of safety. Forward P/E 18.9x stretched relative to 6% growth. Quality metrics strong (ROE 39%, ROA 14%, margin 29%). Insider selling cluster ($4.0M in 90 days), potential headwind. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.0B |
| Beta | 0.55 |
| 52W Range | $112.61 - $155.47 |
| Short Interest | 12.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.90 |
| Forward P/E | 18.9 |
| Current P/E | 19.9 |
| YoY Growth | 5.7% |
| EPS Direction | RISING |

### Technicals

MRS_10 deteriorating from -1.5% to -5.5% (-4.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.5pp (needs >3.0% for momentum thesis). Underperforming sector by 5.7pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.03x) but short-term weakness (below SMA20). MACD histogram bearish (-1.44), momentum weakening. RSI neutral at 42. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.49% (CS: 4) | Weak |
| RSI_14 | 41.8 | Neutral |
| MACD Histogram | -1.44 | Bearish |
| vs SMA20 | 0.956x | Below |
| vs SMA50 | 1.000x | Below |
| vs SMA200 | 1.033x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $139.08
- **Stop Loss:** $130.62 (6.1% risk)
- **Target:** $147.54 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 141
- **Position Value:** $19,610.28
- **Portfolio %:** 19.61%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-02-05 (Est: $1.78)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.56 | $1.86 | +19.2% |
| 2025Q2 | $1.48 | $1.68 | +13.3% |
| 2025Q1 | $1.47 | $1.67 | +13.8% |
| 2024Q4 | $1.37 | $1.60 | +17.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*